Paige
Paige AI is a leading company revolutionizing cancer diagnostics through advanced artificial intelligence technology. They develop AI-powered diagnostic and biomarker applications that assist pathologists in cancer detection, subtyping, and molecular biomarker discovery from tissue samples. Their product suite includes AI applications for prostate, breast, gastrointestinal, and multiple other cancer types, leveraging foundation models trained on millions of pathology slides. Paige also offers AI technology and services including foundation models and AI modules for research and drug development, enabling accelerated clinical trials and biomarker discovery. Their proprietary Paige Alba™ is a multi-modal AI co-pilot designed to streamline pathology workflows and enhance precision medicine. The company operates with a strong focus on clinical-grade AI development, regulatory compliance, and global market access, serving over 800 laboratories and medical institutions across 45+ countries, making it a significant player in precision oncology and computational pathology.
Paige
Paige AI is a leading company revolutionizing cancer diagnostics through advanced artificial intelligence technology. They develop AI-powered diagnostic and biomarker applications that assist pathologists in cancer detection, subtyping, and molecular biomarker discovery from tissue samples. Their product suite includes AI applications for prostate, breast, gastrointestinal, and multiple other cancer types, leveraging foundation models trained on millions of pathology slides. Paige also offers AI technology and services including foundation models and AI modules for research and drug development, enabling accelerated clinical trials and biomarker discovery. Their proprietary Paige Alba™ is a multi-modal AI co-pilot designed to streamline pathology workflows and enhance precision medicine. The company operates with a strong focus on clinical-grade AI development, regulatory compliance, and global market access, serving over 800 laboratories and medical institutions across 45+ countries, making it a significant player in precision oncology and computational pathology.
TL;DR
Focus: AI for digital pathology and cancer diagnostics (diagnostic & biomarker applications)
Headquarters: 33 Irving Place, New York, NY
Key products: Paige Platform, FullFocus® (FDA-cleared viewer), PanCancer Detect (Virchow V2), Paige Alba™
Founding: Founded in 2017, originated at Memorial Sloan Kettering Cancer Center (MSK)
Raised disclosed Series A ($25M) and Series B (closed at $70M); later rounds reported; total funding reported in company snapshot: $220M